Identifying Alzheimer's disease-associated genes related to N6-methyladenosine modification as potential biomarkers through correlation analysis: A retrospective observational study
NeuroMarkers · 2025
DOI: 10.1016/j.neumar.2025.100036 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMarkers, 2025. Verfasst von Lin Yang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan Normal University, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease is a prevalent neurodegenerative disorder characterized by cognitive deficits and abnormal neurological activity. Recent evidence suggests that the pathogenesis of Alzheimer's disease may involve the abnormal expression of specific genes, particularly those associated with N6-methyladenosine modification. N6-methyladenosine is a common mRNA modification that influences mRNA splicing, translation, and stability, thereby regulating physiological processes and potentially contributing to neurodegenerative diseases. Our study aimed to identify and screen genes related to Alzheimer's disease, focusing on the METTL3 gene, a key regulator of m6A modification. We used a novel weighted metrics method that combines the METTL3 gene data with gene chip data from four stages of Alzheimer's disease samples through a Spearman-Cosine correlation weighing technique.By utilizing a correlation coefficient matrix strategy that integrates Spearman correlation and Pinched cosine correlation, we identified nine significantly differentially expressed genes associated with Alzheimer's disease. These genes, which are highly correlated with METTL3 during the transition from normal to disease states, suggest that m6A modification regulates METTL3 expression and affects the pathogenesis of Alzheimer's disease through multiple molecular pathways. Notably, our findings reveal a profound connection between m6A modification and energy metabolism, with observable effects on mitochondrial function, lipid metabolism, and glycolytic pathways. These genes, potentially serving as biomarkers, could advance the development of therapeutic strategies for Alzheimer's disease. Our results highlight the importance of m6A modification in Alzheimer's disease and suggest that the identified genes could be used as biomarkers for early detection and monitoring of the disease. The clinical significance of our findings lies in the potential to develop targeted therapies and improve patient outcomes by enhancing our understanding of the molecular mechanisms underlying Alzheimer's disease.
Förderung
- Sichuan Normal University
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Zheng, P., Huang, C., Gao, C., Pang, X., Liu, H., Wei, Y., & Pang, C. (2025). Identifying Alzheimer's disease-associated genes related to N6-methyladenosine modification as potential biomarkers through correlation analysis: A retrospective observational study. NeuroMarkers. https://doi.org/10.1016/j.neumar.2025.100036
Vancouver
Yang L, Zheng P, Huang C, Gao C, Pang X, Liu H, et al. Identifying Alzheimer's disease-associated genes related to N6-methyladenosine modification as potential biomarkers through correlation analysis: A retrospective observational study. NeuroMarkers. 2025. doi:10.1016/j.neumar.2025.100036
BibTeX
@article{Yang2025,
author = {Yang, Lin and Zheng, Pengtao and Huang, Cong and Gao, Chonghao and Pang, Xinping and Liu, Hui and Wei, Yanyu and Pang, Chaoyang},
title = {Identifying Alzheimer's disease-associated genes related to N6-methyladenosine modification as potential biomarkers through correlation analysis: A retrospective observational study},
journal = {NeuroMarkers},
year = {2025},
doi = {10.1016/j.neumar.2025.100036}
}
EUVIMED